Top Markets
Coin of the day
TheraVet S.A. TheraVet S.A.

TheraVet S.A.

ALVET
Rangering i aksjer #40005
TheraVet S.A. operates as a veterinary biotechnology firm, delivering... TheraVet S.A. operates as a veterinary biotechnology firm, delivering specialized osteoarticular therapies for animals across Belgium, France, Switzerland, the United Kingdom, and the United States. The company's primary focus is on providing solutions for osteoarthritis, ligament and tendon damage, and bone surgery requirements in felines, canines, and equines. Its product lineup includes BIOCERA-VET, formulated to enhance bone integration and remodeling, and VISCO-VET. The latter is an injectable, hyaluronic acid-based gel that facilitates regeneration, exhibits anti-inflammatory characteristics, boosts the effectiveness of active compounds, and promotes cellular colonization essential for tissue repair. Founded in 2017, TheraVet S.A. has its corporate base situated in Jumet, Belgium.
Aksjekurs
$0.08585084
Sist synkronisert: 2025-02-24
Markedsverdi
$276.78K
Endring (1 dag)
0.05%
Endring (1 år)
0.00%
Land
BE
Handel TheraVet S.A. (ALVET)

Kategori

P/S-forhold for TheraVet S.A. (ALVET)
P/S-forhold per 2026 TTM: 0
Ifølge TheraVet S.A. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for TheraVet S.A. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE